Skip to content
Back to COCO

Vita Coco Company, Inc.

Open-market purchases and sales reported on SEC Forms 4 and 5, with each filing and its footnotes.

Since Nov 18, 2025
Transactions
58
Purchases
0
Sales
58
Purchase value
$0.00
Sale value
$75.25M

Values are shares multiplied by reported price when both were supplied, each trade counted once however many filers reported it.

Corey BakerChief Financial Officer
4Rule 10b5-1 plan disclosed
Filed Nov 5, 2026Period of report Nov 3, 20260001482981-26-000187
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleNov 4, 2026
Common StockF15,000$65.00$325.00K24,951Direct
SaleNov 3, 2026
Common StockF11,000$60.00$60.00K24,951Direct
Filing footnotes · 5
  1. F1The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan.
  2. F2The stock option vests in four equal annual installments beginning on March 10, 2024.
  3. F3The stock option is vested as to 40% and will vest the remaining 30% on March 10, 2025, 20% on March 10, 2026 and 10% on March 10, 2027.
  4. F4The stock option vests in four equal annual installments beginning on March 4, 2025.
  5. F5The Reporting Person was granted stock options that will vest in four annual equal installments on each anniversary of the grant date provided that the Reporting Person remains in continuous service on each vesting date.
Open on SEC EDGAR
Kenneth SadowskyDirector
4Rule 10b5-1 plan disclosed
Filed Jun 18, 2026Period of report Jun 17, 20260001482981-26-000162
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJun 17, 2026
Common StockF1F23,900$82.916$323.37K580,296Direct
Filing footnotes · 3
  1. F1The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan.
  2. F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $82.19 to $83.69, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  3. F3The stock option is fully vested and currently exercisable.
Open on SEC EDGAR
Ira LiranDirector
4Rule 10b5-1 plan disclosed
Filed Jun 15, 2026Period of report Jun 12, 20260001482981-26-000160
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJun 12, 2026
Common StockF1F2F374,232$80.292$5.96M309,871Direct
SaleJun 12, 2026
Common StockF1F2F473,842$80.322$5.93M402,579Indirectby Ira Liran 2012 FT
Filing footnotes · 4
  1. F1The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan.
  2. F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $77.40 to $81.42, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  3. F3These shares are held by the Ira Liran Revocable Trust
  4. F4These shares are held by the Ira Liran 2012 Family Trust.
Open on SEC EDGAR
Ira LiranDirector
4Rule 10b5-1 plan disclosed
Filed Jun 12, 2026Period of report Jun 11, 20260001482981-26-000158
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJun 11, 2026
Common StockF1F2F395,768$79.14$7.58M384,103Direct
SaleJun 11, 2026
Common StockF1F4F596,158$79.14$7.61M476,421Indirectby Ira Liran 2012 FT
Filing footnotes · 5
  1. F1The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan.
  2. F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $76.19 to $80.37, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  3. F3These shares are held by the Ira Liran Revocable Trust
  4. F4The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $76.35 to $80.37, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  5. F5These shares are held by the Ira Liran 2012 Family Trust.
Open on SEC EDGAR
Jonathan BurthChief Operating Officer
4Rule 10b5-1 plan disclosed
Filed Jun 12, 2026Period of report Jun 11, 20260001482981-26-000156
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJun 11, 2026
Common StockF130,000$80.00$2.40M57,910Direct
Filing footnotes · 9
  1. F1The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan.
  2. F2The stock option is fully vested and currently exercisable.
  3. F3The stock option is eligible to vest in four tranches if certain performance conditions for each tranche of the option are met by the target date for the applicable performance condition(s) and expire relative to each tranche if the performance conditions for such tranche are not met by the final target date. The performance conditions were partially met and as a result, the first tranche of the option were timely satisfied, resulting in vesting of the option as to 18,200 shares on February 6, 2024. The performance conditions applicable to the fourth tranche of the option were timely satisfied, resulting in vesting of the option as to 22,750 shares on February 20, 2026.
  4. F4The stock option vests in four equal annual installments beginning on November 27, 2022.
  5. F5The stock option vests in three equal annual installments beginning on August 15, 2025.
  6. F6The stock option is eligible to vest if certain performance conditions are met by the target date for the applicable performance condition(s) and expire if the performance conditions are not met by the final target date. The performance conditions applicable were timely satisfied, resulting in vesting of the option as to 14,025 shares on February 20, 2026.
  7. F7The stock option vests in four equal annual installments beginning on March 10, 2024.
  8. F8The stock option vests in four equal annual installments beginning on March 4, 2025.
  9. F9The Reporting Person was granted stock options that will vest in four annual equal installments on each anniversary of the grant date provided that the Reporting Person remains in continuous service on each vesting date.
Open on SEC EDGAR
Charles van EsChief Commercial Officer
4Rule 10b5-1 plan disclosed
Filed Jun 2, 2026Period of report Jun 1, 20260001482981-26-000138
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJun 1, 2026
Common StockF18,045$75.05$603.78K59,085Direct
Filing footnotes · 8
  1. F1The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan.
  2. F2The stock option is fully vested and currently exercisable.
  3. F3The stock option vests in four equal annual installments beginning on November 27, 2022.
  4. F4The stock option vests in three equal annual installments beginning on August 15, 2025.
  5. F5The stock option is eligible to vest if certain performance conditions are met by the target date for the applicable performance condition(s) and expire if the performance conditions are not met by the final target date. The performance conditions applicable were timely satisfied, resulting in vesting of the option as to 14,025 shares on February 20, 2026.
  6. F6The stock options vest in four annual equal installments beginning on March 10, 2024.
  7. F7The stock option vests in four equal annual installments beginning on March 4, 2025.
  8. F8The Reporting Person was granted stock options that will vest in four annual equal installments on each anniversary of the grant date provided that the Reporting Person remains in continuous service on each vesting date.
Open on SEC EDGAR
Kenneth SadowskyDirector
4Rule 10b5-1 plan disclosed
Filed May 21, 2026Period of report May 20, 20260001482981-26-000136
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleMay 20, 2026
Common StockF1F23,900$77.475$302.15K582,666Direct
Filing footnotes · 3
  1. F1The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan.
  2. F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $76.54 to $78.05, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  3. F3The stock option is fully vested and currently exercisable.
Open on SEC EDGAR
Jonathan BurthChief Operating Officer
4Rule 10b5-1 plan disclosed
Filed May 13, 2026Period of report May 12, 20260001482981-26-000134
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleMay 12, 2026
Common StockF130,000$75.00$2.25M57,910Direct
Filing footnotes · 9
  1. F1The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan.
  2. F2The stock option is fully vested and currently exercisable.
  3. F3The stock option is eligible to vest in four tranches if certain performance conditions for each tranche of the option are met by the target date for the applicable performance condition(s) and expire relative to each tranche if the performance conditions for such tranche are not met by the final target date. The performance conditions were partially met and as a result, the first tranche of the option were timely satisfied, resulting in vesting of the option as to 18,200 shares on February 6, 2024. The performance conditions applicable to the fourth tranche of the option were timely satisfied, resulting in vesting of the option as to 22,750 shares on February 20, 2026.
  4. F4The stock option vests in four equal annual installments beginning on November 27, 2022.
  5. F5The stock option vests in three equal annual installments beginning on August 15, 2025.
  6. F6The stock option is eligible to vest if certain performance conditions are met by the target date for the applicable performance condition(s) and expire if the performance conditions are not met by the final target date. The performance conditions applicable were timely satisfied, resulting in vesting of the option as to 14,025 shares on February 20, 2026.
  7. F7The stock option vests in four equal annual installments beginning on March 10, 2024.
  8. F8The stock option vests in four equal annual installments beginning on March 4, 2025.
  9. F9The Reporting Person was granted stock options that will vest in four annual equal installments on each anniversary of the grant date provided that the Reporting Person remains in continuous service on each vesting date.
Open on SEC EDGAR
Jonathan BurthChief Operating Officer
4Rule 10b5-1 plan disclosed
Filed May 11, 2026Period of report May 8, 20260001482981-26-000132
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleMay 8, 2026
Common StockF120,000$70.00$1.40M57,910Direct
Filing footnotes · 9
  1. F1The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan.
  2. F2The stock option is fully vested and currently exercisable.
  3. F3The stock option is eligible to vest in four tranches if certain performance conditions for each tranche of the option are met by the target date for the applicable performance condition(s) and expire relative to each tranche if the performance conditions for such tranche are not met by the final target date. The performance conditions were partially met and as a result, the first tranche of the option were timely satisfied, resulting in vesting of the option as to 18,200 shares on February 6, 2024. The performance conditions applicable to the fourth tranche of the option were timely satisfied, resulting in vesting of the option as to 22,750 shares on February 20, 2026.
  4. F4The stock option vests in four equal annual installments beginning on November 27, 2022.
  5. F5The stock option vests in three equal annual installments beginning on August 15, 2025.
  6. F6The stock option is eligible to vest if certain performance conditions are met by the target date for the applicable performance condition(s) and expire if the performance conditions are not met by the final target date. The performance conditions applicable were timely satisfied, resulting in vesting of the option as to 14,025 shares on February 20, 2026.
  7. F7The stock option vests in four equal annual installments beginning on March 10, 2024.
  8. F8The stock option vests in four equal annual installments beginning on March 4, 2025.
  9. F9The Reporting Person was granted stock options that will vest in four annual equal installments on each anniversary of the grant date provided that the Reporting Person remains in continuous service on each vesting date.
Open on SEC EDGAR
Charles van EsChief Commercial Officer
4Rule 10b5-1 plan disclosed
Filed May 11, 2026Period of report May 8, 20260001482981-26-000130
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleMay 8, 2026
Common StockF18,561$70.00$599.27K67,130Direct
Filing footnotes · 8
  1. F1The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan.
  2. F2The stock option is fully vested and currently exercisable.
  3. F3The stock option vests in four equal annual installments beginning on November 27, 2022.
  4. F4The stock option vests in three equal annual installments beginning on August 15, 2025.
  5. F5The stock option is eligible to vest if certain performance conditions are met by the target date for the applicable performance condition(s) and expire if the performance conditions are not met by the final target date. The performance conditions applicable were timely satisfied, resulting in vesting of the option as to 14,025 shares on February 20, 2026.
  6. F6The stock options vest in four annual equal installments beginning on March 10, 2024.
  7. F7The stock option vests in four equal annual installments beginning on March 4, 2025.
  8. F8The Reporting Person was granted stock options that will vest in four annual equal installments on each anniversary of the grant date provided that the Reporting Person remains in continuous service on each vesting date.
Open on SEC EDGAR
Charles van EsChief Commercial Officer
4Rule 10b5-1 plan disclosed
Filed May 4, 2026Period of report May 1, 20260001482981-26-000128
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleMay 1, 2026
Common StockF12,000$66.87$133.74K75,691Direct
Filing footnotes · 8
  1. F1The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan.
  2. F2The stock option is fully vested and currently exercisable.
  3. F3The stock option vests in four equal annual installments beginning on November 27, 2022.
  4. F4The stock option vests in three equal annual installments beginning on August 15, 2025.
  5. F5The stock option is eligible to vest if certain performance conditions are met by the target date for the applicable performance condition(s) and expire if the performance conditions are not met by the final target date. The performance conditions applicable were timely satisfied, resulting in vesting of the option as to 14,025 shares on February 20, 2026.
  6. F6The stock options vest in four annual equal installments beginning on March 10, 2024.
  7. F7The stock option vests in four equal annual installments beginning on March 4, 2025.
  8. F8The Reporting Person was granted stock options that will vest in four annual equal installments on each anniversary of the grant date provided that the Reporting Person remains in continuous service on each vesting date.
Open on SEC EDGAR
Michael KirbanDirector · Executive Chairman
4Rule 10b5-1 plan disclosed
Filed May 1, 2026Period of report Apr 30, 20260001482981-26-000126
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleApr 30, 2026
Common StockF1F250,000$68.00$3.40M515,681Indirectby M. Kirban Revoc
Filing footnotes · 8
  1. F1The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan.
  2. F2These shares are held by the Michael Kirban Revocable Trust.
  3. F3These shares are held by the Michael Kirban 2010 Trust.
  4. F4The stock option is fully vested and currently exercisable.
  5. F5The stock option vests in four equal annual installments beginning on November 27, 2022.
  6. F6The stock option vests in four equal annual installments beginning on March 10, 2024.
  7. F7The stock option vests in four equal annual installments beginning on March 4, 2025.
  8. F8The Stock Option vests in four equal annual installments beginning in March 3, 2026.
Open on SEC EDGAR
Jonathan BurthChief Operating Officer
4Rule 10b5-1 plan disclosed
Filed May 1, 2026Period of report Apr 29, 20260001482981-26-000124
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleApr 30, 2026
Common StockF120,000$67.50$1.35M57,910Direct
SaleApr 29, 2026
Common StockF120,000$65.00$1.30M77,910Direct
SaleApr 29, 2026
Common StockF120,000$62.50$1.25M57,910Direct
Filing footnotes · 9
  1. F1The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan.
  2. F2The stock option is fully vested and currently exercisable.
  3. F3The stock option is eligible to vest in four tranches if certain performance conditions for each tranche of the option are met by the target date for the applicable performance condition(s) and expire relative to each tranche if the performance conditions for such tranche are not met by the final target date. The performance conditions were partially met and as a result, the first tranche of the option were timely satisfied, resulting in vesting of the option as to 18,200 shares on February 6, 2024. The performance conditions applicable to the fourth tranche of the option were timely satisfied, resulting in vesting of the option as to 22,750 shares on February 20, 2026.
  4. F4The stock option vests in four equal annual installments beginning on November 27, 2022.
  5. F5The stock option vests in three equal annual installments beginning on August 15, 2025.
  6. F6The stock option is eligible to vest if certain performance conditions are met by the target date for the applicable performance condition(s) and expire if the performance conditions are not met by the final target date. The performance conditions applicable were timely satisfied, resulting in vesting of the option as to 14,025 shares on February 20, 2026.
  7. F7The stock option vests in four equal annual installments beginning on March 10, 2024.
  8. F8The stock option vests in four equal annual installments beginning on March 4, 2025.
  9. F9The Reporting Person was granted stock options that will vest in four annual equal installments on each anniversary of the grant date provided that the Reporting Person remains in continuous service on each vesting date.
Open on SEC EDGAR
Martin RoperDirector · Chief Executive Officer
4Rule 10b5-1 plan disclosed
Filed Apr 30, 2026Period of report Apr 28, 20260001482981-26-000122
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleApr 29, 2026
Common StockF1F220,544$59.348$1.22M298,484Direct
SaleApr 28, 2026
Common StockF125,000$51.13$1.28M298,484Direct
Filing footnotes · 10
  1. F1The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan.
  2. F10The stock option vests in four equal annual installments beginning on March 3, 2026.
  3. F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $56.68 to $60.50, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  4. F3These shares are held by the Christopher G. Roper Exempt Family Trust.
  5. F4These shares are held by the Peter S. Roper Exempt Family Trust.
  6. F5These shares are held by the Thomas L. Roper Exempt Family Trust.
  7. F6The stock option is fully vested and currently exercisable.
  8. F7The stock option vests in four equal annual installments beginning on November 27, 2022.
  9. F8The stock option vests in four equal annual installments beginning on March 10, 2024.
  10. F9The stock option vests in four equal annual installments beginning on March 4, 2025.
Open on SEC EDGAR
Martin RoperDirector · Chief Executive Officer
4Rule 10b5-1 plan disclosed
Filed Apr 28, 2026Period of report Apr 24, 20260001482981-26-000114
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleApr 27, 2026
Common StockF125,000$50.00$1.25M298,484Direct
SaleApr 24, 2026
Common StockF125,000$50.00$1.25M298,484Direct
Filing footnotes · 9
  1. F1The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan.
  2. F2These shares are held by the Christopher G. Roper Exempt Family Trust.
  3. F3These shares are held by the Peter S. Roper Exempt Family Trust.
  4. F4These shares are held by the Thomas L. Roper Exempt Family Trust.
  5. F5The stock option is fully vested and currently exercisable.
  6. F6The stock option vests in four equal annual installments beginning on November 27, 2022.
  7. F7The stock option vests in four equal annual installments beginning on March 10, 2024.
  8. F8The stock option vests in four equal annual installments beginning on March 4, 2025.
  9. F9The stock option vests in four equal annual installments beginning on March 3, 2026.
Open on SEC EDGAR
Martin RoperDirector · Chief Executive Officer
4Rule 10b5-1 plan disclosed
Filed Apr 17, 2026Period of report Apr 16, 20260001482981-26-000099
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleApr 16, 2026
Common StockF125,000$50.00$1.25M298,484Direct
Filing footnotes · 9
  1. F1The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan.
  2. F2These shares are held by the Christopher G. Roper Exempt Family Trust.
  3. F3These shares are held by the Peter S. Roper Exempt Family Trust.
  4. F4These shares are held by the Thomas L. Roper Exempt Family Trust.
  5. F5The stock option is fully vested and currently exercisable.
  6. F6The stock option vests in four equal annual installments beginning on November 27, 2022.
  7. F7The stock option vests in four equal annual installments beginning on March 10, 2024.
  8. F8The stock option vests in four equal annual installments beginning on March 4, 2025.
  9. F9The stock option vests in four equal annual installments beginning on March 3, 2026.
Open on SEC EDGAR
Martin RoperDirector · Chief Executive Officer
4Rule 10b5-1 plan disclosed
Filed Apr 16, 2026Period of report Apr 14, 20260001482981-26-000097
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleApr 15, 2026
Common StockF1F225,000$50.107$1.25M298,484Direct
SaleApr 14, 2026
Common StockF125,000$50.00$1.25M298,484Direct
Filing footnotes · 10
  1. F1The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan.
  2. F10The stock option vests in four equal annual installments beginning on March 3, 2026.
  3. F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.00 to $50.30, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  4. F3These shares are held by the Christopher G. Roper Exempt Family Trust.
  5. F4These shares are held by the Peter S. Roper Exempt Family Trust.
  6. F5These shares are held by the Thomas L. Roper Exempt Family Trust.
  7. F6The stock option is fully vested and currently exercisable.
  8. F7The stock option vests in four equal annual installments beginning on November 27, 2022.
  9. F8The stock option vests in four equal annual installments beginning on March 10, 2024.
  10. F9The stock option vests in four equal annual installments beginning on March 4, 2025.
Open on SEC EDGAR
Kenneth SadowskyDirector
4Rule 10b5-1 plan disclosed
Filed Apr 16, 2026Period of report Apr 15, 20260001482981-26-000095
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleApr 15, 2026
Common StockF1F23,900$48.93$190.83K586,566Direct
Filing footnotes · 3
  1. F1The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan.
  2. F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $48.50 to $49.34, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  3. F3The stock option is fully vested and currently exercisable.
Open on SEC EDGAR
Martin RoperDirector · Chief Executive Officer
4Rule 10b5-1 plan disclosed
Filed Apr 14, 2026Period of report Apr 10, 20260001482981-26-000093
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleApr 13, 2026
Common StockF1F34,456$50.549$225.25K298,484Direct
SaleApr 10, 2026
Common StockF1F225,000$50.107$1.25M298,484Direct
Filing footnotes · 11
  1. F1The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan.
  2. F10The stock option vests in four equal annual installments beginning on March 4, 2025.
  3. F11The stock option vests in four equal annual installments beginning on March 3, 2026.
  4. F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.00 to $50.15, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  5. F3The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.00 to $51.10, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  6. F4These shares are held by the Christopher G. Roper Exempt Family Trust.
  7. F5These shares are held by the Peter S. Roper Exempt Family Trust.
  8. F6These shares are held by the Thomas L. Roper Exempt Family Trust.
  9. F7The stock option is fully vested and currently exercisable.
  10. F8The stock option vests in four equal annual installments beginning on November 27, 2022.
  11. F9The stock option vests in four equal annual installments beginning on March 10, 2024.
Open on SEC EDGAR
Martin RoperDirector · Chief Executive Officer
4Rule 10b5-1 plan disclosed
Filed Apr 9, 2026Period of report Apr 7, 20260001482981-26-000088
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleApr 8, 2026
Common StockF1F225,000$50.949$1.27M298,484Direct
SaleApr 7, 2026
Common StockF125,000$50.00$1.25M298,484Direct
Filing footnotes · 10
  1. F1The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan.
  2. F10The stock option vests in four equal annual installments beginning on March 3, 2026.
  3. F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.02 to $51.48, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  4. F3These shares are held by the Christopher G. Roper Exempt Family Trust.
  5. F4These shares are held by the Peter S. Roper Exempt Family Trust.
  6. F5These shares are held by the Thomas L. Roper Exempt Family Trust.
  7. F6The stock option is fully vested and currently exercisable.
  8. F7The stock option vests in four equal annual installments beginning on November 27, 2022.
  9. F8The stock option vests in four equal annual installments beginning on March 10, 2024.
  10. F9The stock option vests in four equal annual installments beginning on March 4, 2025.
Open on SEC EDGAR
Charles van EsChief Commercial Officer
4Rule 10b5-1 plan disclosed
Filed Apr 2, 2026Period of report Apr 1, 20260001482981-26-000086
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleApr 1, 2026
Common StockF12,000$48.67$97.34K77,691Direct
Filing footnotes · 8
  1. F1The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan.
  2. F2The stock option is fully vested and currently exercisable.
  3. F3The stock option vests in four equal annual installments beginning on November 27, 2022.
  4. F4The stock option vests in three equal annual installments beginning on August 15, 2025.
  5. F5The stock option is eligible to vest if certain performance conditions are met by the target date for the applicable performance condition(s) and expire if the performance conditions are not met by the final target date. The performance conditions applicable were timely satisfied, resulting in vesting of the option as to 14,025 shares on February 20, 2026.
  6. F6The stock options vest in four annual equal installments beginning on March 10, 2024.
  7. F7The stock option vests in four equal annual installments beginning on March 4, 2025.
  8. F8The Reporting Person was granted stock options that will vest in four annual equal installments on each anniversary of the grant date provided that the Reporting Person remains in continuous service on each vesting date.
Open on SEC EDGAR
Corey BakerChief Financial Officer
4Rule 10b5-1 plan disclosed
Filed Mar 23, 2026Period of report Mar 19, 20260001482981-26-000084
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleMar 19, 2026
Common StockF12,000$55.45$110.90K25,951Direct
Filing footnotes · 5
  1. F1The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan.
  2. F2The stock option vests in four equal annual installments beginning on March 10, 2024.
  3. F3The stock option is vested as to 40% and will vest the remaining 30% on March 10, 2025, 20% on March 10, 2026 and 10% on March 10, 2027.
  4. F4The stock option vests in four equal annual installments beginning on March 4, 2025.
  5. F5The Reporting Person was granted stock options that will vest in four annual equal installments on each anniversary of the grant date provided that the Reporting Person remains in continuous service on each vesting date.
Open on SEC EDGAR
Corey BakerChief Financial Officer
4Rule 10b5-1 plan disclosed
Filed Mar 19, 2026Period of report Mar 17, 20260001482981-26-000082
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleMar 18, 2026
Common StockF12,000$58.04$116.08K27,951Direct
SaleMar 17, 2026
Common StockF12,000$59.92$119.84K29,951Direct
Filing footnotes · 5
  1. F1The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan.
  2. F2The stock option vests in four equal annual installments beginning on March 10, 2024.
  3. F3The stock option is vested as to 40% and will vest the remaining 30% on March 10, 2025, 20% on March 10, 2026 and 10% on March 10, 2027.
  4. F4The stock option vests in four equal annual installments beginning on March 4, 2025.
  5. F5The Reporting Person was granted stock options that will vest in four annual equal installments on each anniversary of the grant date provided that the Reporting Person remains in continuous service on each vesting date.
Open on SEC EDGAR
Kenneth SadowskyDirector
4Rule 10b5-1 plan disclosed
Filed Mar 19, 2026Period of report Mar 18, 20260001482981-26-000080
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleMar 18, 2026
Common StockF1F23,900$56.918$221.98K590,466Direct
Filing footnotes · 3
  1. F1The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan.
  2. F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $56.54 to $57.77, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  3. F3The stock option is fully vested and currently exercisable.
Open on SEC EDGAR
Jonathan BurthChief Operating Officer
4Rule 10b5-1 plan disclosed
Filed Mar 18, 2026Period of report Mar 16, 20260001482981-26-000078
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleMar 16, 2026
Common StockF120,000$57.98$1.16M57,910Direct
SaleMar 16, 2026
Common StockF18,825$57.98$511.67K57,910Direct
SaleMar 16, 2026
Common StockF111,175$57.98$647.93K57,910Direct
SaleMar 16, 2026
Common StockF120,000$60.00$1.20M57,910Direct
Filing footnotes · 9
  1. F1The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan.
  2. F2The stock option is fully vested and currently exercisable.
  3. F3The stock option is eligible to vest in four tranches if certain performance conditions for each tranche of the option are met by the target date for the applicable performance condition(s) and expire relative to each tranche if the performance conditions for such tranche are not met by the final target date. The performance conditions were partially met and as a result, the first tranche of the option were timely satisfied, resulting in vesting of the option as to 18,200 shares on February 6, 2024. The performance conditions applicable to the fourth tranche of the option were timely satisfied, resulting in vesting of the option as to 22,750 shares on February 20, 2026.
  4. F4The stock option vests in four equal annual installments beginning on November 27, 2022.
  5. F5The stock option vests in three equal annual installments beginning on August 15, 2025.
  6. F6The stock option is eligible to vest if certain performance conditions are met by the target date for the applicable performance condition(s) and expire if the performance conditions are not met by the final target date. The performance conditions applicable were timely satisfied, resulting in vesting of the option as to 14,025 shares on February 20, 2026.
  7. F7The stock option vests in four equal annual installments beginning on March 10, 2024.
  8. F8The stock option vests in four equal annual installments beginning on March 4, 2025.
  9. F9The Reporting Person was granted stock options that will vest in four annual equal installments on each anniversary of the grant date provided that the Reporting Person remains in continuous service on each vesting date.
Open on SEC EDGAR
Charles van EsChief Commercial Officer
4Rule 10b5-1 plan disclosed
Filed Mar 18, 2026Period of report Mar 16, 20260001482981-26-000076
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleMar 16, 2026
Common StockF12,000$57.98$115.96K79,691Direct
Filing footnotes · 8
  1. F1The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan.
  2. F2The stock option is fully vested and currently exercisable.
  3. F3The stock option vests in four equal annual installments beginning on November 27, 2022.
  4. F4The stock option vests in three equal annual installments beginning on August 15, 2025.
  5. F5The stock option is eligible to vest if certain performance conditions are met by the target date for the applicable performance condition(s) and expire if the performance conditions are not met by the final target date. The performance conditions applicable were timely satisfied, resulting in vesting of the option as to 14,025 shares on February 20, 2026.
  6. F6The stock options vest in four annual equal installments beginning on March 10, 2024.
  7. F7The stock option vests in four equal annual installments beginning on March 4, 2025.
  8. F8The Reporting Person was granted stock options that will vest in four annual equal installments on each anniversary of the grant date provided that the Reporting Person remains in continuous service on each vesting date.
Open on SEC EDGAR
Corey BakerChief Financial Officer
4Rule 10b5-1 plan disclosed
Filed Mar 17, 2026Period of report Mar 13, 20260001482981-26-000074
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleMar 16, 2026
Common StockF12,000$57.98$115.96K31,951Direct
SaleMar 13, 2026
Common StockF12,000$58.86$117.72K33,951Direct
Filing footnotes · 5
  1. F1The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan.
  2. F2The stock option vests in four equal annual installments beginning on March 10, 2024.
  3. F3The stock option is vested as to 40% and will vest the remaining 30% on March 10, 2025, 20% on March 10, 2026 and 10% on March 10, 2027.
  4. F4The stock option vests in four equal annual installments beginning on March 4, 2025.
  5. F5The Reporting Person was granted stock options that will vest in four annual equal installments on each anniversary of the grant date provided that the Reporting Person remains in continuous service on each vesting date.
Open on SEC EDGAR
Kenneth SadowskyDirector
4Rule 10b5-1 plan disclosed
Filed Mar 17, 2026Period of report Mar 16, 20260001482981-26-000072
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleMar 16, 2026
Common StockF1F210,000$60.137$601.37K594,366Direct
Filing footnotes · 3
  1. F1The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan.
  2. F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.00 to $60.19, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  3. F3The stock option is fully vested and currently exercisable.
Open on SEC EDGAR
Michael KirbanDirector · Executive Chairman
4Rule 10b5-1 plan disclosed
Filed Mar 13, 2026Period of report Mar 11, 20260001482981-26-000070
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleMar 12, 2026
Common StockF1F240,204$58.00$2.33M565,681Indirectby M. Kirban Revoc
SaleMar 11, 2026
Common StockF1F29,796$58.00$568.17K605,885Indirectby M. Kirban Revoc
Filing footnotes · 8
  1. F1The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan.
  2. F2These shares are held by the Michael Kirban Revocable Trust.
  3. F3These shares are held by the Michael Kirban 2010 Trust.
  4. F4The stock option is fully vested and currently exercisable.
  5. F5The stock option vests in four equal annual installments beginning on November 27, 2022.
  6. F6The stock option vests in four equal annual installments beginning on March 10, 2024.
  7. F7The stock option vests in four equal annual installments beginning on March 4, 2025.
  8. F8The Stock Option vests in four equal annual installments beginning in March 3, 2026.
Open on SEC EDGAR
Jane PriorChief Marketing Officer
4Rule 10b5-1 plan disclosed
Filed Mar 9, 2026Period of report Feb 20, 20260001482981-26-000060
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleMar 5, 2026
Common StockF2F334,159$52.73$1.80M143,240Direct
SaleMar 5, 2026
Common StockF2F415,741$53.32$839.31K127,499Direct
SaleMar 5, 2026
Common StockF2100$54.08$5.41K127,399Direct
Filing footnotes · 11
  1. F1The disposition reported on this Form 4 represents shares withheld to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units. The disposition is mandated by the Issuer and does not represent a discretionary transaction by the Reporting Person.
  2. F10The stock option vests in four equal annual installments beginning on March 4, 2025.
  3. F11The Reporting Person was granted stock options that will vest in four annual equal installments on each anniversary of the grant date provided that the Reporting Person remains in continuous service on each vesting date.
  4. F2The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan.
  5. F3The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $52.07 to $53.06, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  6. F4The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.07 to $53.84, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  7. F5The stock option is eligible to vest if certain performance conditions are met by the target date for the applicable performance condition(s) and expire if the performance conditions are not met by the final target date. The performance conditions applicable were timely satisfied, resulting in vesting of the option as to 14,025 shares on February 20, 2026.
  8. F6The stock option is fully vested and currently exercisable.
  9. F7The stock option vests in four equal annual installments beginning on November 27, 2022.
  10. F8The stock option vests in three equal annual installments beginning on August 15, 2025.
  11. F9The stock options vest in four annual equal installments beginning on March 10, 2024.
Open on SEC EDGAR
John D LeahyDirector
4
Filed Mar 3, 2026Period of report Mar 2, 20260001482981-26-000044
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleMar 2, 2026
Common StockF127,300$56.1857$1.53M17,179Direct
Filing footnotes · 2
  1. F1The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.95 to $56.45, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  2. F2The stock option is fully vested and currently exercisable.
Open on SEC EDGAR
Jane Cecil MorreauDirector
4Rule 10b5-1 plan disclosed
Filed Feb 24, 2026Period of report Feb 23, 20260001482981-26-000026
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleFeb 23, 2026
Common StockF115,000$53.91$808.65K17,179Direct
Filing footnotes · 2
  1. F1The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan.
  2. F2The stock option is fully vested and currently exercisable.
Open on SEC EDGAR
Kenneth SadowskyDirector
4Rule 10b5-1 plan disclosed
Filed Feb 19, 2026Period of report Feb 18, 20260001482981-26-000024
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleFeb 18, 2026
Common StockF1F23,900$55.64$217.00K604,366Direct
Filing footnotes · 3
  1. F1The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan.
  2. F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.17 to $57.24, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  3. F3The stock option is fully vested and currently exercisable.
Open on SEC EDGAR
Ira LiranDirector
4Rule 10b5-1 plan disclosed
Filed Feb 6, 2026Period of report Feb 5, 20260001482981-26-000011
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleFeb 5, 2026
Common StockF1F220,000$56.66$1.13M478,341Direct
SaleFeb 5, 2026
Common StockF1F3F430,000$56.65$1.70M572,579Indirectby Ira Liran 2012 FT
Filing footnotes · 4
  1. F1The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan.
  2. F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.48 to $57.33, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  3. F3The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.70 to $57.36, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  4. F4These shares are held by the Ira Liran 2012 Family Trust.
Open on SEC EDGAR
Kenneth SadowskyDirector
4Rule 10b5-1 plan disclosed
Filed Jan 23, 2026Period of report Jan 21, 20260001482981-26-000009
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJan 21, 2026
Common StockF1F23,900$53.92$210.29K608,266Direct
Filing footnotes · 3
  1. F1The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan.
  2. F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.78 to $54.03, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  3. F3The stock option is fully vested and currently exercisable.
Open on SEC EDGAR
Kenneth SadowskyDirector
4Rule 10b5-1 plan disclosed
Filed Dec 18, 2025Period of report Dec 17, 20250001886372-25-000012
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleDec 17, 2025
Common StockF1F23,900$51.621$201.32K612,166Direct
Filing footnotes · 3
  1. F1The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan.
  2. F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.24 to $52.23, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  3. F3The stock option is fully vested and currently exercisable.
Open on SEC EDGAR
Ira LiranDirector
4Rule 10b5-1 plan disclosed
Filed Nov 25, 2025Period of report Nov 24, 20250001886269-25-000016
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleNov 24, 2025
Common StockF1F225,381$50.294$1.28M498,341Direct
SaleNov 24, 2025
Common StockF1F3F433,862$50.271$1.70M602,579Indirectby Ira Liran 2012 FT
Filing footnotes · 4
  1. F1The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan.
  2. F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.00 to $50.65, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  3. F3The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.00 to $50.62, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  4. F4These shares are held by the Ira Liran 2012 Family Trust.
Open on SEC EDGAR
Kenneth SadowskyDirector
4Rule 10b5-1 plan disclosed
Filed Nov 20, 2025Period of report Nov 19, 20250001886372-25-000010
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleNov 19, 2025
Common StockF1F23,900$47.115$183.75K616,066Direct
Filing footnotes · 3
  1. F1The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan.
  2. F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.32 to $47.45, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  3. F3The stock option is fully vested and currently exercisable.
Open on SEC EDGAR

P and S transaction codes only. Grants, gifts, option exercises, tax withholding, and Form 144 notices are not counted as purchases or sales. A row whose filed price fails a plausibility check, or that is not common stock, is listed but left out of the values; a trade reported by several filers is counted once.